✦ LIBER ✦

Ticagrelor: Oral Reversible P2Y12 Receptor Antagonist for the Management of Acute Coronary Syndromes

✍ Scribed by Judy W.M. Cheng

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ticagrelor: a P2Y 12 antagonist for use

✍ Wijeyeratne, Yanushi Dullewe; Joshi, Rashi; Heptinstall, Stan 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 978 KB

Ticagrelor: The First Reversibly Binding

✍ Steen Husted; J.J.J. Van Giezen 📂 Article 📅 2009 🏛 Hindawi Limited 🌐 English ⚖ 729 KB

Ticagrelor in the management of acute co

✍ Green, S.; Cherian, T.; Heald, C.; Lee, M.; Devlin, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Ticagrelor in the management of acute co

✍ Green, S.; Cherian, T.; Heald, C.; Lee, M.; Devlin, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Inhibition of Platelet Aggregation by AZ

✍ Robert F. Storey; Steen Husted; Robert A. Harrington; Stanley Heptinstall; Rober 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 797 KB

Comparison of ticagrelor, the first reve

✍ Stefan James; Axel Åkerblom; Christopher P. Cannon; Håkan Emanuelsson; Steen Hus 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 139 KB